Literature DB >> 8482561

Relationship between paraaortic lymph node involvement and intraperitoneal spread in patients with ovarian cancer--a multivariate analysis.

N Tsuruchi1, T Kamura, N Tsukamoto, K Akazawa, T Saito, T Kaku, N To, H Nakano.   

Abstract

In 125 patients with epithelial ovarian cancer (FIGO stages I-IV), 32 (26%) had paraaortic lymph node (PAN) metastases. The estimated 5-year survival rate of PAN-negative patients was 71%, while that of PAN-positive patients was 17% (P < 0.0001). Positive rates of PAN metastasis at each stage level, based only on intraperitoneal spread of the disease, were 2% for stage I, 9% for stage II, 43% for stage III, and 87% for stage IV. According to univariate analysis, histological grade, and all disease site parameters examined, such as subdiaphragmatic surface, liver and spleen capsule, intestines and mesentery, omentum, pelvic peritoneum, sigmoid colon and rectum, uterus and tubes, and peritoneal cytology, showed a statistically significant correlation to the presence of PAN metastasis. Multivariate analysis using the logistic regression model revealed that the omental involvement, uterine and tubal involvement, and histological grade were independently correlated with PAN metastasis. The relative risk of PAN metastasis in the patients with these three factors is 18.5 times higher than that in patients without these factors. The present data suggested that, for the disease with omental and/or uterine and tubal involvement, surgical evaluation of PAN is mandatory in order to perform correct FIGO staging.

Entities:  

Mesh:

Year:  1993        PMID: 8482561     DOI: 10.1006/gyno.1993.1085

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  6 in total

1.  Management of lymph nodes in the treatment of gynecologic cancers.

Authors:  Toshiharu Kamura
Journal:  Int J Clin Oncol       Date:  2007-06-27       Impact factor: 3.402

Review 2.  Management of retroperitoneal lymph nodes in the treatment of ovarian cancer.

Authors:  Kimio Ushijima
Journal:  Int J Clin Oncol       Date:  2007-06-27       Impact factor: 3.402

3.  Perimenopausal ovarian carcinoma patient with subclavian node metastasis proven by immunohistochemistry.

Authors:  Hee Jeong Jeong; Hyun Joo Kim; Eun Hee Lee; Hyoun Wook Lee; Min Kyu Kim
Journal:  J Menopausal Med       Date:  2014-04-28

4.  Epithelial-mesenchymal transition in ovarian carcinoma.

Authors:  Ben Davidson; Claes G Tropé; Reuven Reich
Journal:  Front Oncol       Date:  2012-04-10       Impact factor: 6.244

5.  Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis.

Authors:  A Maggioni; P Benedetti Panici; T Dell'Anna; F Landoni; A Lissoni; A Pellegrino; R S Rossi; S Chiari; E Campagnutta; S Greggi; R Angioli; N Manci; M Calcagno; G Scambia; R Fossati; I Floriani; V Torri; R Grassi; C Mangioni
Journal:  Br J Cancer       Date:  2006-08-29       Impact factor: 7.640

6.  Supra-clavicular lymph node metastatic spread in patients with ovarian cancer disclosed at 18F-FDG-PET/CT: an unusual finding.

Authors:  S Fanti; C Nanni; P Castellucci; M Farsad; L Rampin; M D Gross; G Mariani; D Rubello
Journal:  Cancer Imaging       Date:  2006-03-23       Impact factor: 3.909

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.